US2018273594A1PendingUtilityA1
Treatment of retinitis pigmentosa
Est. expirySep 10, 2035(~9.1 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 27/02C12N 2830/008A61K 48/005C12Y 207/11014C07K 14/4702C12N 2800/22C12N 15/86C12N 2750/14171A61K 48/00C12N 2750/14143C12N 9/12
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A polynucleotide comprising a nucleotide sequence encoding the retinitis pigmentosa GTPase regulator ORF15 isoform (RPGR ORF15 ), wherein the RPGR ORF15 -encoding nucleotide sequence has been codon optimised to increase fidelity of replication of the sequence.
Claims
exact text as granted — not AI-modified1 - 48 . (canceled)
49 . A composition comprising a nucleic acid comprising
(a) a sequence encoding a rhodopsin kinase promoter, and (b) a sequence encoding a retinitis pigmentosa GTPase regulator ORF15 isoform (RPGR ORF15 ).
50 . The composition of claim 49 , wherein the rhodopsin kinase promoter is a GRK1 promoter.
51 . The composition of claim 49 or 50 , wherein the sequence encoding the promoter has at least 80% identity to the nucleic acid sequence of SEQ ID NO: 7.
52 . The composition of any one of claims 49 to 51 , wherein the sequence encoding the promoter comprises the nucleic acid sequence of SEQ ID NO: 7.
53 . The composition of any one of claims 49 to 51 , wherein the sequence encoding the promoter consists of the nucleic acid sequence of SEQ ID NO: 7.
54 . The composition of any one of claims 49 to 53 , wherein the sequence encoding the RPGR ORF15 is a human RPGR ORF15 sequence.
55 . The composition of any one of claims 49 to 54 , wherein the sequence encoding the RPGR ORF15 comprises a nucleotide sequence encoding an amino acid sequence that has at least 80% identity to the amino acid sequence of SEQ ID NO: 1.
56 . The composition of any one of claims 49 to 55 , wherein the sequence encoding the RPGR ORF15 comprises a nucleotide sequence that has at least 80% identity to the nucleic acid sequence of SEQ ID NO: 2.
57 . The composition of claim 56 , wherein the sequence encoding the RPGR ORF15 comprises a nucleotide sequence that has at least 97% identity to the nucleic acid sequence of SEQ ID NO: 2.
58 . The composition of any one of claims 49 to 54 , wherein the sequence encoding the RPGR ORF15 comprises a nucleotide sequence that has at least 80% identity to the nucleic acid sequence of SEQ ID NO: 3.
59 . The composition of claim 58 , wherein the sequence encoding the RPGR ORF15 comprises a nucleotide sequence that has at least 97% identity to the nucleic acid sequence of SEQ ID NO: 3.Join the waitlist — get patent alerts
Track US2018273594A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.